765 Results

People

  1. Berger
    Berger
  2. Solit
    Solit
  3. Ladanyi
    Ladanyi
  4. Zehir
    Zehir
  5. Arcila
    Arcila
  6. Schultz
    Schultz
  7. Al-Ahmadie
    Al-Ahmadie
  8. Hyman
    Hyman
  9. Iyer
    Iyer
  10. Stadler
    Stadler

Groups

  1. Center for Molecular Imaging and Biotechnology (CMIB) (765)
  2. Department of Pathology and Laboratory Medicine (765)
  3. GSK Faculty (765)
  4. Human Oncology and Pathogenesis Program (765)
  5. Department of Medicine (607)
  6. Solid Tumor Oncology Division (578)
  7. Genitourinary Oncology Service (355)
  8. Epidemiology and Biostatistics (322)
  9. Surgery (303)
  10. Tow Center for Developmental Oncology (TCDO) (291)
  1. "Michael Berger"
Formats
  1. Meeting Abstract (424)
  2. Journal Article (323)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (765)
  2. Department of Pathology and Laboratory Medicine (765)
  3. GSK Faculty (765)
  4. Human Oncology and Pathogenesis Program (765)
  5. Department of Medicine (607)
  6. Solid Tumor Oncology Division (578)

More Groups

People
  1. Michael Berger (765)
  2. David Solit (315)
  3. Marc Ladanyi (219)
  4. Ahmet Zehir (190)
  5. Maria Arcila (162)
  6. Nikolaus Schultz (157)

More People

Years
  1. 2025 (15)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (154)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (52)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (176)
  2. American Association for Cancer Research (145)
  3. Nature Publishing Group (109)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (46)
  6. Oxford University Press (39)

More Publishers

Results (765)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic and molecular features to distinguish metastatic urothelial carcinoma in lung from primary lung squamous cell carcinoma
    Meeting Abstract

    Rammal, R.; Darmofal, M.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; Reuter, V.; Travis, W.; Berger, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Tumor-infiltrating clonal hematopoiesis
    Journal Article

    Pich, O.; Bernard, E.; Zagorulya, M.; Rowan, A.; Pospori, C.; Slama, R.; Huerga Encabo, H.; O'Sullivan, J.; Papazoglou, D.; Anastasiou, P.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Clinical implications of the cancer genome atlas molecular classification system in esophagogastric cancer
    Journal Article

    Walch, H. S.; Borpatragohain, R.; Jee, J.; Chatila, W.; Fong, C.; Maron, S. B.; Ku, G. Y.; Ilson, D. H.; Janjigian, Y. Y.; Wu, A. J.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Genomic landscape of adenocarcinomas across the gastroesophageal junction moving on from the Siewert classification
    Journal Article

    Nakauchi, M.; Walch, H. S.; Nussenzweig, S.; Carr, R.; Vos, E.; Berger, M. F.; Schultz, N.; Janjigian, Y.; Wu, A.; Tang, L.; more...
    Annals of Surgery (2025)

    Fulltext@MSK | Save
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA and response to cisplatin-based chemotherapy in patients with metastatic urothelial carcinoma enrolled in CALGB 90601 (Alliance)
    Journal Article

    Guercio, B. J.; Whiting, K.; Shah, R. H.; Ballman, K. V.; Halabi, S.; Regazzi, A. M.; Milbank, J. H.; Bajorin, D. F.; Beltran, H.; Morris, M. J.; more...
    European Urology Open Science (2025)

    Fulltext@MSK | Save
  • Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer
    Journal Article

    Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Obesity and biliary tract cancers: Changing epidemiology
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save